Skip to content

Clinical trials

Phase 1 Gastrointestinal Stromal Tumors trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Phase: Phase 1 Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20021
20031
20041
20052
20062
20073
20081
20091
20101
20111
20122
20131
20142
20154
20161
20171
20182
20191
20202
20214
20222
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting5
Terminated4
Unknown status2
Active, not recruiting2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Memorial Sloan Kettering Cancer Center3
Novartis Pharmaceuticals3
Blueprint Medicines Corporation2
Dana-Farber Cancer Institute2
Deciphera Pharmaceuticals, LLC2
Asan Medical Center1
Ascentage Pharma Group Inc.1
Astellas Pharma Inc1
Case Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors45
Stomach Neoplasms9
Sarcoma8
Appendiceal Neoplasms7
Carcinoma, Hepatocellular7
Carcinoma, Non-Small-Cell Lung7
Esophageal Neoplasms7
Gallbladder Neoplasms7
Neoplasms7
Pancreatic Neoplasms7

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.